JNJ-54861911

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

Healthy

Phase 1

A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates

CompletedNCT02211079

Janssen Research & Development, LLCHealthy

Start: 2014-09-30End: 2014-11-30Updated: 2015-11-24

A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants

CompletedNCT02611518

Janssen Research & Development, LLCHealthy

Start: 2016-04-05End: 2016-06-14Updated: 2025-02-03